Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 1,451 | 54 | 0 | 168 | 828 |
| Gross Profit | 1,451 | 54 | N/A | 168 | 828 |
| Operating Expenses | 19,966 | 90,652 | 5,410 | 6,542 | 8,826 |
| Operating Income | -18,515 | -90,598 | -5,410 | -6,374 | -7,998 |
| Interest Expense | 0 | 180 | 93 | 94 | 141 |
| Other Income | 55 | 36 | 9 | 33 | 95 |
| Pre-tax Income | -18,460 | -90,742 | -5,494 | -6,435 | -8,044 |
| Net Income Continuous | -18,460 | -90,742 | -5,494 | -6,435 | -8,044 |
| Net Income | $-18,460 | $-90,742 | $-5,494 | $-6,435 | $-8,044 |
| EPS Basic Total Ops | -2.91 | -25.18 | -1.48 | -1.82 | -2.65 |
| EPS Basic Continuous Ops | -2.91 | -25.18 | -1.48 | -1.82 | -2.65 |
| EPS Diluted Total Ops | -2.91 | -25.18 | -1.48 | -1.82 | -2.65 |
| EPS Diluted Continuous Ops | -2.91 | -25.18 | -1.48 | -1.82 | -2.65 |
| EBITDA(a) | $-18,250 | $-90,491 | $-5,354 | $-6,028 | $-7,931 |